BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17878687)

  • 1. Type 1 neurofibromatosis complicated by pulmonary artery hypertension: a case report.
    Simeoni S; Puccetti A; Chilosi M; Tinazzi E; Prati D; Corrocher R; Lunardi C
    J Med Invest; 2007 Aug; 54(3-4):354-8. PubMed ID: 17878687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?
    Stewart DR; Cogan JD; Kramer MR; Miller WT; Christiansen LE; Pauciulo MW; Messiaen LM; Tu GS; Thompson WH; Pyeritz RE; Ryu JH; Nichols WC; Kodama M; Meyrick BO; Ross DJ
    Chest; 2007 Sep; 132(3):798-808. PubMed ID: 17573495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension in patients with neurofibromatosis type I.
    Montani D; Coulet F; Girerd B; Eyries M; Bergot E; Mal H; Biondi G; Dromer C; Hugues T; Marquette C; O'Connell C; O'Callaghan DS; Savale L; Jaïs X; Dorfmüller P; Begueret H; Bertoletti L; Sitbon O; Bellanné-Chantelot C; Zalcman G; Simonneau G; Humbert M; Soubrier F
    Medicine (Baltimore); 2011 May; 90(3):201-211. PubMed ID: 21512413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
    Jutant EM; Jaïs X; Girerd B; Savale L; Ghigna MR; Perros F; Mignard X; Jevnikar M; Bourlier D; Prevot G; Tromeur C; Bauer F; Bergot E; Dauphin C; Favrolt N; Traclet J; Soumagne T; De Groote P; Chabanne C; Magro P; Bertoletti L; Gueffet JP; Chaouat A; Goupil F; Moceri P; Borie R; Fadel E; Wolkenstein P; Brillet PY; Simonneau G; Sitbon O; Humbert M; Montani D
    Am J Respir Crit Care Med; 2020 Sep; 202(6):843-852. PubMed ID: 32437637
    [No Abstract]   [Full Text] [Related]  

  • 5. Type 1 neurofibromatosis complicated by pulmonary arterial hypertension: A case report.
    Küçük M; Öncel CR; Uçar M; Yıldırım AB
    Turk Kardiyol Dern Ars; 2017 Jul; 45(5):458-461. PubMed ID: 28694401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary artery hypertension in childhood: The transforming growth factor-β superfamily-related genes.
    Yuan SM
    Pediatr Neonatol; 2018 Apr; 59(2):112-119. PubMed ID: 28967497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials.
    Jurasz P; Courtman D; Babaie S; Stewart DJ
    Pharmacol Ther; 2010 Apr; 126(1):1-8. PubMed ID: 20117135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMPR2 gene mutation in pulmonary arteriovenous malformation and pulmonary hypertension: a case report.
    Handa T; Okano Y; Nakanishi N; Morisaki T; Morisaki H; Mishima M
    Respir Investig; 2014 May; 52(3):195-8. PubMed ID: 24853021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic characteristics of pulmonary arterial hypertension in Lebanon.
    Abou Hassan OK; Haidar W; Nemer G; Skouri H; Haddad F; BouAkl I
    BMC Med Genet; 2018 May; 19(1):89. PubMed ID: 29843651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutations in the gene encoding bone morphogenetic protein receptor 2 in patients with idiopathic pulmonary arterial hypertension].
    Baloira A; Vilariño C; Leiro V; Valverde D
    Arch Bronconeumol; 2008 Jan; 44(1):29-34. PubMed ID: 18221724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Female gender and pulmonary arterial hypertension: a complex relationship].
    Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
    G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
    Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
    Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in neurofibromatosis.
    Engel PJ; Baughman RP; Menon SG; Kereiakes DJ; Taylor L; Scott M
    Am J Cardiol; 2007 Apr; 99(8):1177-8. PubMed ID: 17437753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
    Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
    Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology of the great vessels in patients with pulmonary arterial hypertension in association with congenital heart disease: large pulmonary arteries matter too.
    Prapa M; McCarthy KP; Dimopoulos K; Sheppard MN; Krexi D; Swan L; Wort SJ; Gatzoulis MA; Ho SY
    Int J Cardiol; 2013 Oct; 168(3):2248-54. PubMed ID: 23453874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension associated with neurofibromatosis type 1.
    Jutant EM; Girerd B; Jaïs X; Savale L; O'Connell C; Perros F; Sitbon O; Humbert M; Montani D
    Eur Respir Rev; 2018 Sep; 27(149):. PubMed ID: 30158278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in a Polish population of patients with pulmonary arterial hypertension: sequencing of BMPR2, ALK1, and ENG genes.
    Uznańska-Loch B; Wikło K; Kulczycka-Wojdala D; Szymańska B; Chrzanowski Ł; Wierzbowska-Drabik K; Trzos E; Kasprzak JD; Kurpesa M
    Kardiol Pol; 2018; 76(5):852-859. PubMed ID: 29350394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension: a fatal complication of neurofibromatosis type 1.
    Gumbiene L; Petrulioniene Z; Rucinskas K; Maneikiene V; Serpytis P; Dranenkiene A; Laucevicius A
    Respir Care; 2011 Nov; 56(11):1844-8. PubMed ID: 21605478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.